The Influence of c-Kit and NRAS Mutation on Patients’ Survival in Metastatic Melanoma Receiving Immune Checkpoint Inhibitors and Chemotherapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details